Journal
ORAL SCIENCE INTERNATIONAL
Volume 13, Issue 1, Pages 1-6Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1348-8643(15)00038-5
Keywords
NF-kappa B; Bone invasion; Oral squamous cell carcinoma
Categories
Funding
- Grants-in-Aid for Scientific Research [26462792, 26870543] Funding Source: KAKEN
Ask authors/readers for more resources
Oral squamous cell carcinoma (OSCC) is the most common malignant tumor in the oral cavity and the head and neck region. Gingival squamous cell carcinomas (SCCs) frequently invade the maxilla or the mandibular bone and are associated with poor prognosis. Recent findings suggest that osteoclasts, rather than OSCC cells, mediate invasion to the bone. Nuclear factor-kappa B (NF-kappa B) is constitutively activated in OSCCs and is involved in promoting the invasive characteristics of OSCC. NF-kappa B activation is also important for receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis. NF-kappa B inhibitors suppress proliferation and stimulate apoptosis of OSCC cells in vitro and in vivo, as well as inhibit matrix metalloproteinase (MMP) production in OSCC. Furthermore, NF-kappa B inhibitors have been shown to suppress osteoclastogenesis by reducing RANKL expression in animal models. Thus, inhibition of NF-kappa B activity may constitute a promising therapeutic approach to treat bone-invasive OSCC. In this review, we discuss recent findings, which suggest that bone invasion in OSCC is mediated via NF-kappa B signaling and may be successfully prevented by NF-kappa B inhibition. (C) 2015 Japanese Stomatological Society. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available